Clinical Trial Update: Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on PSMA-based PET imaging for primary prostate cancer across Phase 1 and Phase 2 completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-08-28